July/August 2008 Volume 1 Number 3 • HOPA Sets Goals for Future Growth of Oncology Pharmacy • AMCP: Strategies for Navigating Oncology Management Discussed at Symposium • ASCO: Oral Immunosuppressant Enhances PFS in Resistant Metastatic RCC • ASCO: Bisphosphonate Prolongs Cancer-free Survival in Endocrinesensitive Breast Cancer • ASCO: Low Vitamin D Associated with Worse Outcomes in Patients with Breast Cancer • HOPA: Myelosuppression Decreases Response Rates, HRQOL in Patients with CML • Profile: H. Lee Moffitt Cancer Center & Research Institute •Calculating the Dosage of Anticancer Drugs in Obese Patients: A Clinical Challenge • Oral Mucositis: The Challenging Issues Facing Oncology Clinicians • AUA: Finasteride May Help Reduce the Risk of Most Prostate Cancers • Trends in Prostate Cancer • Trends in Lung Cancer • Trends in Hematologic Cancer